33 results on '"Corredera, C."'
Search Results
2. Rosacea fulminans in pregnancy: successful treatment with azithromycin
- Author
-
Fuentelsaz, V., Ara, M., Corredera, C., Lezcano, V., Juberias, P., and Carapeto, F. J.
- Published
- 2011
- Full Text
- View/download PDF
3. Pregnancy-Related Erythema Annulare Centrifugum
- Author
-
Fuentelsaz, V., Corredera, C., Ara, M., and Carapeto, F.J.
- Published
- 2011
- Full Text
- View/download PDF
4. Eritema anular centrífugo asociado a gestación
- Author
-
Fuentelsaz, V., Corredera, C., Ara, M., and Carapeto, F.J.
- Published
- 2011
- Full Text
- View/download PDF
5. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
- Author
-
Stacey, S.N., Sulem, P., Jonasdottir, A., Masson, G., Gudmundsson, J., Gudbjartsson, D.F., Magnusson, O.T., Gudjonsson, S.A., Sigurgeirsson, B., Thorisdottir, K., Ragnarsson, R., Benediktsdottir, K.R., Nexo, B.A., Tjonneland, A., Overvad, K., Rudnai, P., Gurzau, E, Koppova, K., Hemminki, K., Corredera, C., Fuentelsaz, V., Grasa, P., Navarrete, S., Fuertes, F., Garcia-Prats, M.D., Sanambrosio, E., Panadero, A., Juan, A. de, Garcia, A., Rivera, F., Planelles, D., Soriano, V., Requena, C., Aben, K.K.H., Rossum, M.M. van, Cremers, R.G.H.M., Oort, I.M. van, Spronsen, D.J. van, Schalken, J.A., Peters, W.H.M., Helfand, B.T., Donovan, J.L., Hamdy, F.C., Badescu, D., Codreanu, O., Jinga, M., Csiki, I.E., Constantinescu, V., Badea, P., Mates, I.N., Dinu, D.E., Constantin, A., Mates, D., Kristjansdottir, S., Agnarsson, B.A., Jonsson, E., Barkardottir, R.B., Einarsson, G.V., Sigurdsson, F., Moller, P.H., Stefansson, T., Valdimarsson, T., Johannsson, O.T., Sigurdsson, H., Jonsson, T., Jonasson, J.G., Tryggvadottir, L., Rice, T., Hansen, H.M., Xiao, Y., Lachance, D.H., Kosel, M.L., Decker, P.A., Thorleifsson, G., Johannsdottir, H., Helgadottir, H.T., Sigurdsson, A., Steinthorsdottir, V., Lindblom, A., Sandler, R.S., Keku, T.O., Banasik, K., Jorgensen, T., Witte, D.R., Hansen, T., Pedersen, O., Jinga, V., Neal, D.E., Catalona, W.J., Wrensch, M., Wiencke, J., Jenkins, R.B., Nagore, E., Vogel, U., Kiemeney, L.A.L.M., Kumar, R., Mayordomo, J.I., Olafsson, J.H., et al., Stacey, S.N., Sulem, P., Jonasdottir, A., Masson, G., Gudmundsson, J., Gudbjartsson, D.F., Magnusson, O.T., Gudjonsson, S.A., Sigurgeirsson, B., Thorisdottir, K., Ragnarsson, R., Benediktsdottir, K.R., Nexo, B.A., Tjonneland, A., Overvad, K., Rudnai, P., Gurzau, E, Koppova, K., Hemminki, K., Corredera, C., Fuentelsaz, V., Grasa, P., Navarrete, S., Fuertes, F., Garcia-Prats, M.D., Sanambrosio, E., Panadero, A., Juan, A. de, Garcia, A., Rivera, F., Planelles, D., Soriano, V., Requena, C., Aben, K.K.H., Rossum, M.M. van, Cremers, R.G.H.M., Oort, I.M. van, Spronsen, D.J. van, Schalken, J.A., Peters, W.H.M., Helfand, B.T., Donovan, J.L., Hamdy, F.C., Badescu, D., Codreanu, O., Jinga, M., Csiki, I.E., Constantinescu, V., Badea, P., Mates, I.N., Dinu, D.E., Constantin, A., Mates, D., Kristjansdottir, S., Agnarsson, B.A., Jonsson, E., Barkardottir, R.B., Einarsson, G.V., Sigurdsson, F., Moller, P.H., Stefansson, T., Valdimarsson, T., Johannsson, O.T., Sigurdsson, H., Jonsson, T., Jonasson, J.G., Tryggvadottir, L., Rice, T., Hansen, H.M., Xiao, Y., Lachance, D.H., Kosel, M.L., Decker, P.A., Thorleifsson, G., Johannsdottir, H., Helgadottir, H.T., Sigurdsson, A., Steinthorsdottir, V., Lindblom, A., Sandler, R.S., Keku, T.O., Banasik, K., Jorgensen, T., Witte, D.R., Hansen, T., Pedersen, O., Jinga, V., Neal, D.E., Catalona, W.J., Wrensch, M., Wiencke, J., Jenkins, R.B., Nagore, E., Vogel, U., Kiemeney, L.A.L.M., Kumar, R., Mayordomo, J.I., Olafsson, J.H., and et al.
- Abstract
Contains fulltext : 97569.pdf (publisher's version ) (Closed access), To identify new risk variants for cutaneous basal cell carcinoma, we performed a genome-wide association study of 16 million SNPs identified through whole-genome sequencing of 457 Icelanders. We imputed genotypes for 41,675 Illumina SNP chip-typed Icelanders and their relatives. In the discovery phase, the strongest signal came from rs78378222[C] (odds ratio (OR) = 2.36, P = 5.2 x 10(-17)), which has a frequency of 0.0192 in the Icelandic population. We then confirmed this association in non-Icelandic samples (OR = 1.75, P = 0.0060; overall OR = 2.16, P = 2.2 x 10(-20)). rs78378222 is in the 3' untranslated region of TP53 and changes the AATAAA polyadenylation signal to AATACA, resulting in impaired 3'-end processing of TP53 mRNA. Investigation of other tumor types identified associations of this SNP with prostate cancer (OR = 1.44, P = 2.4 x 10(-6)), glioma (OR = 2.35, P = 1.0 x 10(-5)) and colorectal adenoma (OR = 1.39, P = 1.6 x 10(-4)). However, we observed no effect for breast cancer, a common Li-Fraumeni syndrome tumor (OR = 1.06, P = 0.57, 95% confidence interval 0.88-1.27).
- Published
- 2011
6. New common variants affecting susceptibility to basal cell carcinoma.
- Author
-
Stacey, S.N., Sulem, P., Masson, G., Gudjonsson, S.A., Thorleifsson, G., Jakobsdottir, M., Sigurdsson, A., Gudbjartsson, D.F., Sigurgeirsson, B., Benediktsdottir, K.R., Thorisdottir, K., Ragnarsson, R., Scherer, D., Hemminki, K., Rudnai, P., Gurzau, E, Koppova, K., Botella-Estrada, R., Soriano, V., Juberias, P., Saez, B., Gilaberte, Y., Fuentelsaz, V., Corredera, C., Grasa, M., Hoiom, V., Lindblom, A., Bonenkamp, J.J., Rossum, M.M. van, Aben, K.K.H., Vries, E. de, Santinami, M., Mauro, M.G. Di, Maurichi, A., Wendt, J., Hochleitner, P., Pehamberger, H., Gudmundsson, J., Magnusdottir, D.N., Gretarsdottir, S., Holm, H., Steinthorsdottir, V., Frigge, M.L., Blondal, T., Saemundsdottir, J., Bjarnason, H., Kristjansson, K., Bjornsdottir, G., Okamoto, I., Rivoltini, L., Rodolfo, M., Kiemeney, L.A.L.M., Hansson, J., Nagore, E., Mayordomo, J.I., Kumar, R., Karagas, M.R., Nelson, H.H., Gulcher, J.R., Rafnar, T., Thorsteinsdottir, U., Olafsson, J.H., Kong, A., Stefansson, K., Stacey, S.N., Sulem, P., Masson, G., Gudjonsson, S.A., Thorleifsson, G., Jakobsdottir, M., Sigurdsson, A., Gudbjartsson, D.F., Sigurgeirsson, B., Benediktsdottir, K.R., Thorisdottir, K., Ragnarsson, R., Scherer, D., Hemminki, K., Rudnai, P., Gurzau, E, Koppova, K., Botella-Estrada, R., Soriano, V., Juberias, P., Saez, B., Gilaberte, Y., Fuentelsaz, V., Corredera, C., Grasa, M., Hoiom, V., Lindblom, A., Bonenkamp, J.J., Rossum, M.M. van, Aben, K.K.H., Vries, E. de, Santinami, M., Mauro, M.G. Di, Maurichi, A., Wendt, J., Hochleitner, P., Pehamberger, H., Gudmundsson, J., Magnusdottir, D.N., Gretarsdottir, S., Holm, H., Steinthorsdottir, V., Frigge, M.L., Blondal, T., Saemundsdottir, J., Bjarnason, H., Kristjansson, K., Bjornsdottir, G., Okamoto, I., Rivoltini, L., Rodolfo, M., Kiemeney, L.A.L.M., Hansson, J., Nagore, E., Mayordomo, J.I., Kumar, R., Karagas, M.R., Nelson, H.H., Gulcher, J.R., Rafnar, T., Thorsteinsdottir, U., Olafsson, J.H., Kong, A., and Stefansson, K.
- Abstract
Contains fulltext : 81164.pdf (publisher's version ) (Closed access), In a follow-up to our previously reported genome-wide association study of cutaneous basal cell carcinoma (BCC), we describe here several new susceptibility variants. SNP rs11170164, encoding a G138E substitution in the keratin 5 (KRT5) gene, affects risk of BCC (OR = 1.35, P = 2.1 x 10(-9)). A variant at 9p21 near CDKN2A and CDKN2B also confers susceptibility to BCC (rs2151280[C]; OR = 1.19, P = 6.9 x 10(-9)), as does rs157935[T] at 7q32 near the imprinted gene KLF14 (OR = 1.23, P = 5.7 x 10(-10)). The effect of rs157935[T] is dependent on the parental origin of the risk allele. None of these variants were found to be associated with melanoma or fair-pigmentation traits. A melanoma- and pigmentation-associated variant in the SLC45A2 gene, L374F, is associated with risk of both BCC and squamous cell carcinoma. Finally, we report conclusive evidence that rs401681[C] in the TERT-CLPTM1L locus confers susceptibility to BCC but protects against melanoma.
- Published
- 2009
7. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
- Author
-
Rafnar, T., Tjø, nneland, A., Grasa, P., Mates, D., Jinga, V., Hansen, T., Sigurgeirsson, B., Nagore, E., Hemminki, K., Badescu, D., Panadero, A., Steinthorsdottir, V., Jø, rgensen, T., Rudnai, P., Mayordomo, Ji, Stacey, Sn, Helfand, Bt, Peters, Wh, Garcí, a-prats, Md, Lachance, Dh, Jenkins, Rb, Agnarsson, Ba, Gurzau, E., Sulem, P., Banasik, K., Masson, G., Thorisdottir, K., Constantinescu, V., Corredera, C., Rossum, Mm, Overvad, K., Requena, C., Ragnarsson, R., Kristjansdottir, S., Jonsson, T., Planelles, D., Fuertes, F., Badea, P., Mates, In, Johannsson, Ot, Jinga, M., Rice, T., Constantin, A., Wrensch, M., Sigurdsson, H., Spronsen, Dj, Hamdy, Fc, Kumar, R., Oort, Im, Johannsdottir, H., Tryggvadottir, L., Rivera, F., Stefansson, T., Dinu, DE, Keku, To, Moller, Ph, Kosel, Ml, Csiki, Ie, Gudjonsson, Sa, Benediktsdottir, Kr, Decker, Pa, Sandler, Rs, Aben, Kk, Pedersen, O., Wiencke, J., Soriano, V., Sanambrosio, E., Navarrete, S., Garcia, A., Jonsson, E., Barkardottir, Rb, Stefansson, K., Neal, DE, Gudbjartsson, Df, Juan, A., Donovan, Jl, Codreanu, O., Lindblom, A., Fuentelsaz, V., Gudmundsson, J., Witte, Dr, Kiemeney, La, Xiao, Y., Kong, A., Jonasdottir, A., Olafsson, Jh, Cremers, Rg, Nexø, Einarsson, Gv, Hansen, Hm, Helgadottir, Ht, Catalona, Wj, Magnusson, Ot, O Neill, Bp, Thorleifsson, G., Sigurdsson, F., Thorsteinsdottir, U., Valdimarsson, T., Vogel, U., Jonasson, Jg, Schalken, Ja, Sigurdsson, A., and Koppova, K.
8. Estructura histológica de la piel de los camélidos sudamericanos.
- Author
-
Lacolla, D., García, M., Corredera, C., and Buey, V.
- Subjects
- *
SKIN physiology , *GUANACO , *LLAMAS , *VICUNA , *HISTOLOGY , *CYTOLOGY , *HAIR follicle physiology , *CUTANEOUS glands - Abstract
Skin histological structure of South American camel It was described the histological and cytological characteristics of the skin of the guanaco (Lama guanicoe), llama (L. glama), vicuna (V. vicugna) and crosses of guanaco and llama of first generation. Special attention was paid to aspects of the epidermis, hair follicles and glands. The epidermis is thick in the head and neck of guanaco, llama and crosses, and generally thin in inguinal, axillary regions and all across the skin of the vicuña. Hair follicles can occur in isolation or in groups, according to the skin area and species. When looking at these groups may consist of a large follicle or principal and various accessories. Primary follicles produce hair and accessory follicules can produce hair or wool fibers. The total number of follicles per unit area is highest in the vicuña. The sweat glands are numerous and deep location. They are mostly apocrine type. There is at least one per follicular group. The sebaceous glands are, in general, simple existing almost always a small unit in each hair follicle although some may not possess. They are located superficially and its secretion is holocrine. In individuals crossing guanaco and llama, intermediate values were observed, but generally close to those of the guanaco. [ABSTRACT FROM AUTHOR]
- Published
- 2010
9. Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy
- Author
-
Diana Velázquez-Carreras, Kathleen M. Ruppel, Fernando Domínguez, Divya Pathak, David Sánchez-Ortiz, Neha Nandwani, Jorge Alegre-Cebollada, Carmen Suay-Corredera, Silvia Vilches, Pablo García-Pavía, Lorenzo Monserrat, James A. Spudich, David De Sancho, Maria Rosaria Pricolo, Carolina Pimenta-Lopes, Giulia Frisso, Elías Herrero-Galán, Iñigo Urrutia-Irazabal, Suay-Corredera, C., Pricolo, M. R., Velazquez-Carreras, D., Pathak, D., Nandwani, N., Pimenta-Lopes, C., Sanchez-Ortiz, D., Urrutia-Irazabal, I., Vilches, S., Dominguez, F., Frisso, G., Monserrat, L., Garcia-Pavia, P., De Sancho, D., Spudich, J. A., Ruppel, K. M., Herrero-Galan, E., Alegre-Cebollada, J., Ministerio de Ciencia e Innovación (España), European Research Area Network on Cardiovascular Diseases, Comunidad de Madrid (España), Stanford Maternal and Child Health Research Institute, Instituto de Salud Carlos III, Fundación ProCNIC, Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España), Centro de Investigación Biomédica en Red - CIBERCV (Enfermedades Cardiovasculares), Agencia Estatal de Investigación (España), and Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
- Subjects
Sarcomeres ,cMyBP-C ,Mutant ,General Physics and Astronomy ,02 engineering and technology ,010402 general chemistry ,medicine.disease_cause ,01 natural sciences ,Article ,Protein structure ,Myosin ,Molecular motor ,medicine ,Humans ,General Materials Science ,Mutation ,Chemistry ,Binding protein ,General Engineering ,contraction ,Cardiomyopathy, Hypertrophic ,hypertrophic cardiomyopathy ,021001 nanoscience & nanotechnology ,Phenotype ,0104 chemical sciences ,Cell biology ,RNA splicing ,protein mechanic ,single-molecule ,AFM ,0210 nano-technology ,Carrier Proteins - Abstract
Hypertrophic cardiomyopathy (HCM) is a disease of the myocardium caused by mutations in sarcomeric proteins with mechanical roles, such as the molecular motor myosin. Around half of the HCM-causing genetic variants target contraction modulator cardiac myosin-binding protein C (cMyBP-C), although the underlying pathogenic mechanisms remain unclear since many of these mutations cause no alterations in protein structure and stability. As an alternative pathomechanism, here we have examined whether pathogenic mutations perturb the nanomechanics of cMyBP-C, which would compromise its modulatory mechanical tethers across sliding actomyosin filaments. Using single-molecule atomic force spectroscopy, we have quantified mechanical folding and unfolding transitions in cMyBP-C domains targeted by HCM mutations that do not induce RNA splicing alterations or protein thermodynamic destabilization. Our results show that domains containing mutation R495W are mechanically weaker than wild-type at forces below 40 pN and that R502Q mutant domains fold faster than wild-type. None of these alterations are found in control, nonpathogenic variants, suggesting that nanomechanical phenotypes induced by pathogenic cMyBP-C mutations contribute to HCM development. We propose that mutation-induced nanomechanical alterations may be common in mechanical proteins involved in human pathologies. J.A.C. acknowledges funding from the Ministerio de Ciencia e Innovación (MCIN) through grants BIO2014– 54768-P, BIO2017–83640-P (AEI/FEDER, UE), EIN2019–102966, RYC-2014–16604, and BFU2017–90692 REDT, the European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, MINOTAUR, AC16/00045), and the Comunidad de Madrid (consortium Tec4Bio-CM, S2018/NMT-4443, FEDER). This work was supported by NIH grants RM1 GM33289 and HL117138 to J.A.S.; a Stanford Dean’s Postdoctoral Fellowship to D.P. and N.N.; and a Stanford Maternal and Child Health Research Institute (MCHRI) Postdoctoral Fellowship (1220552–140-DHPEU) to N.N. Financial support to D.D.S. comes from Eusko Jaurlaritza (Basque Government) through the project IT1254–19, and grants RYC-2016–19590 and PGC2018–099321-B-I00 from the MCIN (FEDER). The CNIC is supported by the Instituto de Salud Carlos III (ISCIII), MCIN, and the Pro CNIC Foundation and was a Severo Ochoa Center of Excellence (SEV-2015–0505). We acknowledge funding from ISCIII to the Centro de Investigación Biomédica en Red (CIBERCV), CB16/11/00425. C.S.C. is the recipient of an FPI-SO predoctoral fellowship, BES-2016–076638. M.R.P. was the recipient of a Ph.D. fellowship from the Italian Ministry of Education, Universities and Research (MIUR). C.P.L. was a recipient of a CNIC Master Fellowship. We thank N. Vicente for excellent technical support (through grant PEJ16/MED/TL-1593 from Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid and the European Social Fund). We thank the Spectroscopy and Nuclear Magnetic Resonance Core Unit at CNIO for access to CD instrumentation and discussion about protein binding assays. We thank A. Thompson and S. Day for their insights. We thank all members of the Molecular Mechanics of the Cardiovascular System team for helpful discussions and the contribution of five anonymous reviewers. Sí
- Published
- 2021
10. SISTEMA TEGUMENTARIO DE LA VICUÑA (V. vicugna).
- Author
-
Lacolla, D. V., García, M. G., Hernández, Corredera, C. S., and Von Lawzewitsch, I.
- Subjects
- *
VETERINARY medicine , *ANIMAL health , *ANIMAL diseases , *VICUGNA (Genus) , *CAMELIDAE - Abstract
Samples of different cutaneous areas of mature vicuñas (V. vicugna) were studied microscopically. Thickness of skin, annexed glands and pileous follicles were considered. Follicular groups were of variable siza according to area and contained a greater quantity of follicles in back skin than the flanks. There were also main and secondary follicles within the follicular groups. [ABSTRACT FROM AUTHOR]
- Published
- 2001
11. Microtubule forces drive nuclear damage in LMNA cardiomyopathy.
- Author
-
Pavlov DA, Heffler J, Suay-Corredera C, Dehghany M, Shen KM, Zuela-Sopilniak N, Randell R, Uchida K, Jain R, Shenoy V, Lammerding J, and Prosser B
- Abstract
Nuclear homeostasis requires a balance of forces between the cytoskeleton and nucleus. Mutations in the LMNA gene, which encodes the nuclear envelope proteins lamin A/C, disrupt this balance by weakening the nuclear lamina. This results in nuclear damage in contractile tissues and ultimately muscle disease. Intriguingly, disrupting the LINC complex that connects the cytoskeleton to the nucleus has emerged as a promising strategy to ameliorate LMNA- associated cardiomyopathy. Yet how LINC complex disruption protects the cardiomyocyte nucleus remains unclear. To address this, we developed an assay to quantify the coupling of cardiomyocyte contraction to nuclear deformation and interrogated its dependence on the nuclear lamina and LINC complex. We found that, surprisingly, the LINC complex was mostly dispensable for transferring contractile strain to the nucleus, and that increased nuclear strain in lamin A/C - deficient cardiomyocytes was not rescued by LINC complex disruption. Instead, LINC complex disruption eliminated the cage of microtubules encircling the nucleus. Disrupting microtubules was sufficient to prevent nuclear damage and rescue cardiac function induced by lamin A/C deficiency. We computationally simulated the stress fields surrounding cardiomyocyte nuclei and show how microtubule forces generate local vulnerabilities that damage lamin A/C-deficient nuclei. Our work pinpoints localized, microtubule-dependent force transmission through the LINC complex as a pathological driver and therapeutic target for LMNA- cardiomyopathy.
- Published
- 2024
- Full Text
- View/download PDF
12. "Synthetic Map": A Graphic Organizer Inspired by Artificial Neural Network Paradigms for Learning Organic Synthesis.
- Author
-
Luque-Corredera C, Bartolomé E, and Bradshaw B
- Abstract
Organic Chemistry is widely recognized as a challenging subject, with the design of syntheses and retrosyntheses identified as particularly difficult tasks. Inspired by the success of artificial neural networks in machine learning, we propose a framework that leverages similar principles to enhance the teaching and learning of organic synthesis. In this paper, we introduce a novel teaching tool, the "Synthetic Map", that attempts to visually recreate an expert's mental map and conceptual understanding of organic synthesis built over years of experience. The educational benefits of the Synthetic Map were evaluated through its implementation in an Organic Chemistry course of a Pharmacy degree over two years. The new tool promoted students' learning by providing a mental organizer fostering a deeper understanding of the subject and empowering students to design and execute effective synthetic strategies., Competing Interests: The authors declare no competing financial interest., (© 2024 The Authors. Published by American Chemical Society and Division of Chemical Education, Inc.)
- Published
- 2024
- Full Text
- View/download PDF
13. Enterolignans: from natural origins to cardiometabolic significance, including chemistry, dietary sources, bioavailability, and activity.
- Author
-
Laveriano-Santos EP, Luque-Corredera C, Trius-Soler M, Lozano-Castellón J, Dominguez-López I, Castro-Barquero S, Vallverdú-Queralt A, Lamuela-Raventós RM, and Pérez M
- Abstract
The enterolignans, enterolactone and enterodiol, the main metabolites produced from plant lignans by the gut microbiota, have enhanced bioavailability and activity compared to their precursors, with beneficial effects on metabolic and cardiovascular health. Although extensively studied, the biosynthesis, cardiometabolic effects, and other therapeutic implications of mammalian lignans are still incompletely understood. The aim of this review is to provide a comprehensive overview of these phytoestrogen metabolites based on up-to-date information reported in studies from a wide range of disciplines. Established and novel synthetic strategies are described, as are the various lignan precursors, their dietary sources, and a proposed metabolic pathway for their conversion to enterolignans. The methodologies used for enterolignan analysis and the available data on pharmacokinetics and bioavailability are summarized and their cardiometabolic bioactivity is explored in detail. The special focus given to research on the health benefits of microbial-derived lignan metabolites underscores the critical role of lignan-rich diets in promoting cardiovascular health.
- Published
- 2024
- Full Text
- View/download PDF
14. Mesotherapy with Bicalutamide: A New Treatment for Androgenetic Alopecia.
- Author
-
Gomez-Zubiaur A, Andres-Lencina JJ, Cabezas V, Corredera C, di Brisco F, Ferrer B, Rodriguez-Villa A, Subiabre-Ferrer D, Valenzuela C, Diez DV, and Ricart JM
- Abstract
Bicalutamide is a selective androgen receptor antagonist. To date, it has been used orally with good efficacy results, but not in mesotherapy. In our center, we assessed whether patients undergoing bicalutamide mesotherapy showed positive responses and tolerated the local administration of bicalutamide. Six premenopausal women, with a mean age of 35.7 years and clinical diagnosis of Olsen Grade II or III female androgenetic alopecia accompanied by significant seborrhea were treated with 1 ml bicalutamide 0.5% mesotherapy. Three monthly sessions were performed. A subtle improvement in hair density was described after the third session. The overall satisfaction of the patients with the treatment was 6.3, on a scale of 1-10. Premenopausal women require several therapeutic approaches to combat severe androgenetic alopecia. Our data showed that bicalutamide mesotherapy was well tolerated and welcomed by the patients; we, therefore, provide a new tool for the management of this pathology., Competing Interests: There are no conflicts of interest., (Copyright: © 2023 International Journal of Trichology.)
- Published
- 2023
- Full Text
- View/download PDF
15. Successful Response to a Combination of Intralesional Methotrexate and Fractional CO 2 Laser in Refractory Alopecia Areata: Case Report.
- Author
-
Rodríguez-Villa Lario A, Aguado-García Á, Andrés-Lencina JJ, Corredera C, García-Legaz Martínez M, Alonso de Celada RM, Subiabre-Ferrer D, Valenzuela-Oñate C, Ricart-Vayá JM, and Gómez-Zubiaur A
- Abstract
Introduction: Refractory cases of alopecia areata (AA) may be considered a therapeutic challenge. Intralesional methotrexate (IL-MTX) has been used in other dermatological diseases rather than AA. Likewise, its topical use as an immunosuppressant drug may be of interest for the control of the lymphoid infiltrate in AA. On the other hand, the use of fractional ablative laser is supported in literature as an alternative or complementary treatment in AA, whilst the generation of columns of thermal damage may favour the migration of cells and cytokines that are beneficial., Case Presentation: In this paper, we present 2 cases in which IL-MTX and ablative fractional CO
2 laser were combined with excellent outcomes., Conclusion: Previous research encompasses a total of 23 patients. Most patients presented with patchy AA. The doses administered ranged from 2.5 to 50 mg with an average frequency of 3 weeks. On average, most patients required a minimum of 3 sessions. One case employed 1% topical methotrexate ointment. Adverse local events were mild and transient. In conclusion, the concomitant application of these treatments has not been reported previously. Specific recommendations relating to the appropriate dosing of the drug, frequency of administration, and requirements for analytical control studies should be determined in further studies., Competing Interests: The authors have no conflicts of interest to declare., (Copyright © 2022 by S. Karger AG, Basel.)- Published
- 2022
- Full Text
- View/download PDF
16. Basal oxidation of conserved cysteines modulates cardiac titin stiffness and dynamics.
- Author
-
Herrero-Galán E, Martínez-Martín I, Sánchez-González C, Vicente N, Bonzón-Kulichenko E, Calvo E, Suay-Corredera C, Pricolo MR, Fernández-Trasancos Á, Velázquez-Carreras D, Careaga CB, Abdellatif M, Sedej S, Rainer PP, Giganti D, Pérez-Jiménez R, Vázquez J, and Alegre-Cebollada J
- Subjects
- Animals, Connectin chemistry, Cysteine metabolism, Elasticity, Humans, Mice, Myocardium metabolism, Oxidation-Reduction, Protein Kinases genetics, Protein Kinases metabolism, Heart Diseases metabolism, Sarcomeres metabolism
- Abstract
Titin, as the main protein responsible for the passive stiffness of the sarcomere, plays a key role in diastolic function and is a determinant factor in the etiology of heart disease. Titin stiffness depends on unfolding and folding transitions of immunoglobulin-like (Ig) domains of the I-band, and recent studies have shown that oxidative modifications of cryptic cysteines belonging to these Ig domains modulate their mechanical properties in vitro. However, the relevance of this mode of titin mechanical modulation in vivo remains largely unknown. Here, we describe the high evolutionary conservation of titin mechanical cysteines and show that they are remarkably oxidized in murine cardiac tissue. Mass spectrometry analyses indicate a similar landscape of basal oxidation in murine and human myocardium. Monte Carlo simulations illustrate how disulfides and S-thiolations on these cysteines increase the dynamics of the protein at physiological forces, while enabling load- and isoform-dependent regulation of titin stiffness. Our results demonstrate the role of conserved cysteines in the modulation of titin mechanical properties in vivo and point to potential redox-based pathomechanisms in heart disease., (Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. The mechanics of the heart: zooming in on hypertrophic cardiomyopathy and cMyBP-C.
- Author
-
Suay-Corredera C and Alegre-Cebollada J
- Subjects
- Cytoskeletal Proteins metabolism, Humans, Mutation, Myocytes, Cardiac metabolism, Sarcomeres genetics, Sarcomeres metabolism, Cardiomyopathy, Hypertrophic genetics, Cardiomyopathy, Hypertrophic metabolism, Carrier Proteins metabolism
- Abstract
Hypertrophic cardiomyopathy (HCM), a disease characterized by cardiac muscle hypertrophy and hypercontractility, is the most frequently inherited disorder of the heart. HCM is mainly caused by variants in genes encoding proteins of the sarcomere, the basic contractile unit of cardiomyocytes. The most frequently mutated among them is MYBPC3, which encodes cardiac myosin-binding protein C (cMyBP-C), a key regulator of sarcomere contraction. In this review, we summarize clinical and genetic aspects of HCM and provide updated information on the function of the healthy and HCM sarcomere, as well as on emerging therapeutic options targeting sarcomere mechanical activity. Building on what is known about cMyBP-C activity, we examine different pathogenicity drivers by which MYBPC3 variants can cause disease, focussing on protein haploinsufficiency as a common pathomechanism also in nontruncating variants. Finally, we discuss recent evidence correlating altered cMyBP-C mechanical properties with HCM development., (© 2022 Federation of European Biochemical Societies.)
- Published
- 2022
- Full Text
- View/download PDF
18. The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity.
- Author
-
Del Fresno C, García-Arriaza J, Martínez-Cano S, Heras-Murillo I, Jarit-Cabanillas A, Amores-Iniesta J, Brandi P, Dunphy G, Suay-Corredera C, Pricolo MR, Vicente N, López-Perrote A, Cabezudo S, González-Corpas A, Llorca O, Alegre-Cebollada J, Garaigorta U, Gastaminza P, Esteban M, and Sancho D
- Subjects
- Administration, Mucosal, Animals, Antibodies, Viral immunology, CD8-Positive T-Lymphocytes immunology, COVID-19 immunology, COVID-19 Vaccines administration & dosage, Immunity, Heterologous, Immunity, Innate, Immunogenicity, Vaccine, Immunoglobulin A immunology, Immunologic Factors administration & dosage, Immunologic Factors immunology, Mice, Vaccination, Bacteria immunology, COVID-19 prevention & control, COVID-19 Vaccines immunology, SARS-CoV-2 immunology
- Abstract
COVID-19-specific vaccines are efficient prophylactic weapons against SARS-CoV-2 virus. However, boosting innate responses may represent an innovative way to immediately fight future emerging viral infections or boost vaccines. MV130 is a mucosal immunotherapy, based on a mixture of whole heat-inactivated bacteria, that has shown clinical efficacy against recurrent viral respiratory infections. Herein, we show that the prophylactic intranasal administration of this immunotherapy confers heterologous protection against SARS-CoV-2 infection in susceptible K18-hACE2 mice. Furthermore, in C57BL/6 mice, prophylactic administration of MV130 improves the immunogenicity of two different COVID-19 vaccine formulations targeting the SARS-CoV-2 spike (S) protein, inoculated either intramuscularly or intranasally. Independently of the vaccine candidate and vaccination route used, intranasal prophylaxis with MV130 boosted S-specific responses, including CD8
+ -T cell activation and the production of S-specific mucosal IgA antibodies. Therefore, the bacterial mucosal immunotherapy MV130 protects against SARS-CoV-2 infection and improves COVID-19 vaccines immunogenicity., Competing Interests: SM-C is an employee of Inmunotek S.L. DS laboratory holds a collaboration agreement between CNIC and Inmunotek. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 del Fresno, García-Arriaza, Martínez-Cano, Heras-Murillo, Jarit-Cabanillas, Amores-Iniesta, Brandi, Dunphy, Suay-Corredera, Pricolo, Vicente, López-Perrote, Cabezudo, González-Corpas, Llorca, Alegre-Cebollada, Garaigorta, Gastaminza, Esteban and Sancho.)- Published
- 2021
- Full Text
- View/download PDF
19. Correspondence on "Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation" by Thompson et al.
- Author
-
Suay-Corredera C and Alegre-Cebollada J
- Subjects
- Cytoskeletal Proteins, Humans, Pedigree, Risk Assessment, Cardiomyopathy, Hypertrophic diagnosis, Cardiomyopathy, Hypertrophic genetics
- Published
- 2021
- Full Text
- View/download PDF
20. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
- Author
-
Suay-Corredera C, Pricolo MR, Herrero-Galán E, Velázquez-Carreras D, Sánchez-Ortiz D, García-Giustiniani D, Delgado J, Galano-Frutos JJ, García-Cebollada H, Vilches S, Domínguez F, Molina MS, Barriales-Villa R, Frisso G, Sancho J, Serrano L, García-Pavía P, Monserrat L, and Alegre-Cebollada J
- Subjects
- Cardiomyopathy, Hypertrophic pathology, Carrier Proteins chemistry, Carrier Proteins ultrastructure, Cytoskeletal Proteins chemistry, Cytoskeletal Proteins genetics, Cytoskeletal Proteins ultrastructure, Female, Humans, Male, Molecular Dynamics Simulation, Mutation genetics, Phenotype, Cardiomyopathy, Hypertrophic genetics, Carrier Proteins genetics, Haploinsufficiency genetics, RNA Splicing genetics
- Abstract
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Variants in MYBPC3, the gene encoding cardiac myosin-binding protein C (cMyBP-C), are the leading cause of HCM. However, the pathogenicity status of hundreds of MYBPC3 variants found in patients remains unknown, as a consequence of our incomplete understanding of the pathomechanisms triggered by HCM-causing variants. Here, we examined 44 nontruncating MYBPC3 variants that we classified as HCM-linked or nonpathogenic according to cosegregation and population genetics criteria. We found that around half of the HCM-linked variants showed alterations in RNA splicing or protein stability, both of which can lead to cMyBP-C haploinsufficiency. These protein haploinsufficiency drivers associated with HCM pathogenicity with 100% and 94% specificity, respectively. Furthermore, we uncovered that 11% of nontruncating MYBPC3 variants currently classified as of uncertain significance in ClinVar induced one of these molecular phenotypes. Our strategy, which can be applied to other conditions induced by protein loss of function, supports the idea that cMyBP-C haploinsufficiency is a fundamental pathomechanism in HCM., Competing Interests: Conflict of interest L. M. holds share in Health in Code. All other authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
21. Nanomechanical Phenotypes in Cardiac Myosin-Binding Protein C Mutants That Cause Hypertrophic Cardiomyopathy.
- Author
-
Suay-Corredera C, Pricolo MR, Velázquez-Carreras D, Pathak D, Nandwani N, Pimenta-Lopes C, Sánchez-Ortiz D, Urrutia-Irazabal I, Vilches S, Dominguez F, Frisso G, Monserrat L, García-Pavía P, de Sancho D, Spudich JA, Ruppel KM, Herrero-Galán E, and Alegre-Cebollada J
- Subjects
- Carrier Proteins genetics, Humans, Mutation, Phenotype, Sarcomeres, Cardiomyopathy, Hypertrophic genetics
- Abstract
Hypertrophic cardiomyopathy (HCM) is a disease of the myocardium caused by mutations in sarcomeric proteins with mechanical roles, such as the molecular motor myosin. Around half of the HCM-causing genetic variants target contraction modulator cardiac myosin-binding protein C (cMyBP-C), although the underlying pathogenic mechanisms remain unclear since many of these mutations cause no alterations in protein structure and stability. As an alternative pathomechanism, here we have examined whether pathogenic mutations perturb the nanomechanics of cMyBP-C, which would compromise its modulatory mechanical tethers across sliding actomyosin filaments. Using single-molecule atomic force spectroscopy, we have quantified mechanical folding and unfolding transitions in cMyBP-C domains targeted by HCM mutations that do not induce RNA splicing alterations or protein thermodynamic destabilization. Our results show that domains containing mutation R495W are mechanically weaker than wild-type at forces below 40 pN and that R502Q mutant domains fold faster than wild-type. None of these alterations are found in control, nonpathogenic variants, suggesting that nanomechanical phenotypes induced by pathogenic cMyBP-C mutations contribute to HCM development. We propose that mutation-induced nanomechanical alterations may be common in mechanical proteins involved in human pathologies.
- Published
- 2021
- Full Text
- View/download PDF
22. Cbt modulates Foxo activation by positively regulating insulin signaling in Drosophila embryos.
- Author
-
Muñoz-Soriano V, Belacortu Y, Sanz FJ, Solana-Manrique C, Dillon L, Suay-Corredera C, Ruiz-Romero M, Corominas M, and Paricio N
- Abstract
In late Drosophila embryos, the epidermis exhibits a dorsal hole as a consequence of germ band retraction. It is sealed during dorsal closure (DC), a morphogenetic process in which the two lateral epidermal layers converge towards the dorsal midline and fuse. We previously demonstrated the involvement of the Cbt transcription factor in Drosophila DC. However its molecular role in the process remained obscure. In this study, we used genomic approaches to identify genes regulated by Cbt as well as its direct targets during late embryogenesis. Our results reveal a complex transcriptional circuit downstream of Cbt and evidence that it is functionally related with the Insulin/insulin-like growth factor signaling pathway. In this context, Cbt may act as a positive regulator of the pathway, leading to the repression of Foxo activity. Our results also suggest that the DC defects observed in cbt embryos could be partially due to Foxo overactivation and that a regulatory feedback loop between Foxo and Cbt may be operating in the DC context., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
23. Stimuli-Responsive Functionalization Strategies to Spatially and Temporally Control Surface Properties: Michael vs Diels-Alder Type Additions.
- Author
-
Kyvik AR, Luque-Corredera C, Pulido D, Royo M, Veciana J, Guasch J, and Ratera I
- Abstract
Stimuli-responsive self-assembled monolayers (SAMs) are used to confer switchable physical, chemical, or biological properties to surfaces through the application of external stimuli. To obtain spatially and temporally tunable surfaces, we present microcontact printed SAMs of a hydroquinone molecule that are used as a dynamic interface to immobilize different functional molecules either via Diels-Alder or Michael thiol addition reactions upon the application of a low potential. In spite of the use of such reactions and the potential applicability of the resulting surfaces in different fields ranging from sensing to biomedicine through data storage or cleanup, a direct comparison of the two functionalization strategies on a surface has not yet been performed. Although the Michael thiol addition requires molecules that are commercial or easy to synthesize in comparison with the cyclopentadiene derivatives needed for the Diels-Alder reaction, the latter reaction produces more homogeneous coverages under similar experimental conditions.
- Published
- 2018
- Full Text
- View/download PDF
24. New basal cell carcinoma susceptibility loci.
- Author
-
Stacey SN, Helgason H, Gudjonsson SA, Thorleifsson G, Zink F, Sigurdsson A, Kehr B, Gudmundsson J, Sulem P, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Fuentelsaz V, Corredera C, Gilaberte Y, Grasa M, Planelles D, Sanmartin O, Rudnai P, Gurzau E, Koppova K, Nexø BA, Tjønneland A, Overvad K, Jonasson JG, Tryggvadottir L, Johannsdottir H, Kristinsdottir AM, Stefansson H, Masson G, Magnusson OT, Halldorsson BV, Kong A, Rafnar T, Thorsteinsdottir U, Vogel U, Kumar R, Nagore E, Mayordomo JI, Gudbjartsson DF, Olafsson JH, and Stefansson K
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Case-Control Studies, Child, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Iceland, Male, Membrane Proteins, Middle Aged, N-Myc Proto-Oncogene Protein, White People genetics, Young Adult, Carcinoma, Basal Cell genetics, Caspase 8 genetics, GATA3 Transcription Factor genetics, Homeodomain Proteins genetics, Nuclear Proteins genetics, Oncogene Proteins genetics, Proteins genetics, Skin Neoplasms genetics, Transcription Factors genetics
- Abstract
In an ongoing screen for DNA sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conduct a genome-wide association study (GWAS) of 24,988,228 SNPs and small indels detected through whole-genome sequencing of 2,636 Icelanders and imputed into 4,572 BCC patients and 266,358 controls. Here we show the discovery of four new BCC susceptibility loci: 2p24 MYCN (rs57244888[C], OR=0.76, P=4.7 × 10(-12)), 2q33 CASP8-ALS2CR12 (rs13014235[C], OR=1.15, P=1.5 × 10(-9)), 8q21 ZFHX4 (rs28727938[G], OR=0.70, P=3.5 × 10(-12)) and 10p14 GATA3 (rs73635312[A], OR=0.74, P=2.4 × 10(-16)). Fine mapping reveals that two variants correlated with rs73635312[A] occur in conserved binding sites for the GATA3 transcription factor. In addition, expression microarrays and RNA-seq show that rs13014235[C] and a related SNP rs700635[C] are associated with expression of CASP8 splice variants in which sequences from intron 8 are retained.
- Published
- 2015
- Full Text
- View/download PDF
25. A gram-scale route to phlegmarine alkaloids: rapid total synthesis of (-)-cermizine B.
- Author
-
Bradshaw B, Luque-Corredera C, and Bonjoch J
- Subjects
- Molecular Structure, Stereoisomerism, Alkaloids chemical synthesis, Biological Products chemical synthesis, Lycopodium, Piperidines chemical synthesis, Quinolines chemical synthesis
- Abstract
The synthesis of the Lycopodium alkaloid (-)-cermizine B (1), which establishes its absolute configuration, is achieved by combining asymmetric organocatalysis and an uninterrupted eight-step reaction sequence, followed by a final reduction step. This "pot-economy" strategy provides access to the cis-phlegmarine stereoparent embedded in 1 for the first time, rapidly and on a gram-scale.
- Published
- 2014
- Full Text
- View/download PDF
26. Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma.
- Author
-
Stacey SN, Sulem P, Gudbjartsson DF, Jonasdottir A, Thorleifsson G, Gudjonsson SA, Masson G, Gudmundsson J, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Fuentelsaz V, Corredera C, Grasa M, Planelles D, Sanmartin O, Rudnai P, Gurzau E, Koppova K, Hemminki K, Nexø BA, Tjønneland A, Overvad K, Johannsdottir H, Helgadottir HT, Thorsteinsdottir U, Kong A, Vogel U, Kumar R, Nagore E, Mayordomo JI, Rafnar T, Olafsson JH, and Stefansson K
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Genetic Predisposition to Disease, Genome-Wide Association Study, Genotype, Germ Cells metabolism, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Skin Neoplasms genetics, Young Adult, Antigens, Surface genetics, Carcinoma, Basal Cell genetics, GTP-Binding Protein Regulators genetics, Genetic Variation, Germ-Line Mutation, Transglutaminases genetics
- Abstract
To search for new sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conducted a genome-wide association study of 38.5 million single nucleotide polymorphisms (SNPs) and small indels identified through whole-genome sequencing of 2230 Icelanders. We imputed genotypes for 4208 BCC patients and 109 408 controls using Illumina SNP chip typing data, carried out association tests and replicated the findings in independent population samples. We found new BCC susceptibility loci at TGM3 (rs214782[G], P = 5.5 × 10(-17), OR = 1.29) and RGS22 (rs7006527[C], P = 8.7 × 10(-13), OR = 0.77). TGM3 encodes transglutaminase type 3, which plays a key role in production of the cornified envelope during epidermal differentiation.
- Published
- 2014
- Full Text
- View/download PDF
27. Synthetic and DFT studies towards a unified approach to phlegmarine alkaloids: aza-Michael intramolecular processes leading to 5-oxodecahydroquinolines.
- Author
-
Bradshaw B, Luque-Corredera C, Saborit G, Cativiela C, Dorel R, Bo C, and Bonjoch J
- Abstract
A diastereoselective synthesis of cis-5-oxodecahydroquinolines is described in which three stereocenters are generated in a one-pot reaction. The reaction involves a lithium hydroxide-promoted Robinson annulation/intramolecular aza-Michael domino process from an achiral acyclic tosylamine-tethered β-keto ester. The development and scope of this reaction was facilitated through the use of DFT-based mechanistic studies, which enabled the observed diastereodivergent course of the azacyclization to be rationalized. The varying stereochemistry and stability of the resulting decahydroquinolines was found to depend on whether a β-keto ester or ketone were embedded in the substrates undergoing aminocyclization. This synthetic approach gave access not only to both diastereomeric cis-decahydroquinolines from the same precursor, but also to the corresponding trans isomers, through an epimerization processes of the corresponding N-unsubstituted cis-5-oxodecahydroquinolines. The described methodology provides advanced building-blocks with the three relative stereochemistries required for the total synthesis of phlegmarine alkaloids., (Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.)
- Published
- 2013
- Full Text
- View/download PDF
28. cis-Decahydroquinolines via asymmetric organocatalysis: application to the total synthesis of lycoposerramine Z.
- Author
-
Bradshaw B, Luque-Corredera C, and Bonjoch J
- Subjects
- Alkaloids chemistry, Cyclic N-Oxides chemistry, Lycopodium chemistry, Molecular Structure, Quinolines chemistry, Stereoisomerism, Alkaloids chemical synthesis, Cyclic N-Oxides chemical synthesis, Quinolines chemical synthesis
- Abstract
A concise synthesis of the Lycopodium alkaloid lycoposerramine Z is reported. Key to the strategy is a one-pot organocatalyzed Michael reaction followed by a domino Robinson annulation/intramolecular aza-Michael reaction promoted by LiOH, leading to enantiopure cis-decahydroquinolines.
- Published
- 2013
- Full Text
- View/download PDF
29. [Rectal prolapse repair using transanal endoscopic surgery].
- Author
-
Serra-Aracil X, Alcántara M, Corredera C, Mora L, and Navarro S
- Subjects
- Aged, Anal Canal, Humans, Male, Endoscopy, Gastrointestinal methods, Rectal Prolapse surgery
- Abstract
Rectal prolapse repair techniques using laparoscopic abdominal surgery are the treatments of choice. However, in patients with increased morbidity, perineal surgical techniques are indicated. Transanal endoscopic surgery is presented as a possible alternative option in groups with increased experience in it., (Copyright © 2012 AEC. Published by Elsevier Espana. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
30. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.
- Author
-
Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexø BA, Tjønneland A, Overvad K, Rudnai P, Gurzau E, Koppova K, Hemminki K, Corredera C, Fuentelsaz V, Grasa P, Navarrete S, Fuertes F, García-Prats MD, Sanambrosio E, Panadero A, De Juan A, Garcia A, Rivera F, Planelles D, Soriano V, Requena C, Aben KK, van Rossum MM, Cremers RG, van Oort IM, van Spronsen DJ, Schalken JA, Peters WH, Helfand BT, Donovan JL, Hamdy FC, Badescu D, Codreanu O, Jinga M, Csiki IE, Constantinescu V, Badea P, Mates IN, Dinu DE, Constantin A, Mates D, Kristjansdottir S, Agnarsson BA, Jonsson E, Barkardottir RB, Einarsson GV, Sigurdsson F, Moller PH, Stefansson T, Valdimarsson T, Johannsson OT, Sigurdsson H, Jonsson T, Jonasson JG, Tryggvadottir L, Rice T, Hansen HM, Xiao Y, Lachance DH, O Neill BP, Kosel ML, Decker PA, Thorleifsson G, Johannsdottir H, Helgadottir HT, Sigurdsson A, Steinthorsdottir V, Lindblom A, Sandler RS, Keku TO, Banasik K, Jørgensen T, Witte DR, Hansen T, Pedersen O, Jinga V, Neal DE, Catalona WJ, Wrensch M, Wiencke J, Jenkins RB, Nagore E, Vogel U, Kiemeney LA, Kumar R, Mayordomo JI, Olafsson JH, Kong A, Thorsteinsdottir U, Rafnar T, and Stefansson K
- Subjects
- Humans, Polymorphism, Single Nucleotide, Tumor Suppressor Protein p53 genetics, Genetic Predisposition to Disease, Germ-Line Mutation, Neoplasms genetics, Tumor Suppressor Protein p53 metabolism
- Abstract
To identify new risk variants for cutaneous basal cell carcinoma, we performed a genome-wide association study of 16 million SNPs identified through whole-genome sequencing of 457 Icelanders. We imputed genotypes for 41,675 Illumina SNP chip-typed Icelanders and their relatives. In the discovery phase, the strongest signal came from rs78378222[C] (odds ratio (OR) = 2.36, P = 5.2 × 10(-17)), which has a frequency of 0.0192 in the Icelandic population. We then confirmed this association in non-Icelandic samples (OR = 1.75, P = 0.0060; overall OR = 2.16, P = 2.2 × 10(-20)). rs78378222 is in the 3' untranslated region of TP53 and changes the AATAAA polyadenylation signal to AATACA, resulting in impaired 3'-end processing of TP53 mRNA. Investigation of other tumor types identified associations of this SNP with prostate cancer (OR = 1.44, P = 2.4 × 10(-6)), glioma (OR = 2.35, P = 1.0 × 10(-5)) and colorectal adenoma (OR = 1.39, P = 1.6 × 10(-4)). However, we observed no effect for breast cancer, a common Li-Fraumeni syndrome tumor (OR = 1.06, P = 0.57, 95% confidence interval 0.88-1.27).
- Published
- 2011
- Full Text
- View/download PDF
31. Annular lipoatrophic panniculitis of the ankles.
- Author
-
Corredera C, Iglesias M, Hernández-Martín A, Colmenero I, Dilme E, and Torrelo A
- Subjects
- Adolescent, Atrophy, Biopsy, Female, Humans, Ankle, Connective Tissue Diseases pathology, Panniculitis pathology, Subcutaneous Fat pathology
- Abstract
We report a girl with lipophagic lobular panniculitis of unknown origin located on her ankles leading to circumferential fat atrophy of the ankles, a condition usually referred to as "annular lipoatrophy of the ankles." According to our patient's features and five additional cases reported so far, we conclude that this condition is actually an end-stage manifestation of an idiopathic lobular panniculitis of children localized to the lower part of the lower limbs. An association with some autoimmune manifestations is highlighted., (© 2011 Wiley Periodicals, Inc.)
- Published
- 2011
- Full Text
- View/download PDF
32. New common variants affecting susceptibility to basal cell carcinoma.
- Author
-
Stacey SN, Sulem P, Masson G, Gudjonsson SA, Thorleifsson G, Jakobsdottir M, Sigurdsson A, Gudbjartsson DF, Sigurgeirsson B, Benediktsdottir KR, Thorisdottir K, Ragnarsson R, Scherer D, Hemminki K, Rudnai P, Gurzau E, Koppova K, Botella-Estrada R, Soriano V, Juberias P, Saez B, Gilaberte Y, Fuentelsaz V, Corredera C, Grasa M, Höiom V, Lindblom A, Bonenkamp JJ, van Rossum MM, Aben KK, de Vries E, Santinami M, Di Mauro MG, Maurichi A, Wendt J, Hochleitner P, Pehamberger H, Gudmundsson J, Magnusdottir DN, Gretarsdottir S, Holm H, Steinthorsdottir V, Frigge ML, Blondal T, Saemundsdottir J, Bjarnason H, Kristjansson K, Bjornsdottir G, Okamoto I, Rivoltini L, Rodolfo M, Kiemeney LA, Hansson J, Nagore E, Mayordomo JI, Kumar R, Karagas MR, Nelson HH, Gulcher JR, Rafnar T, Thorsteinsdottir U, Olafsson JH, Kong A, and Stefansson K
- Subjects
- Carcinoma, Basal Cell complications, Carcinoma, Squamous Cell genetics, Chromosomes, Human, Pair 7 genetics, Chromosomes, Human, Pair 9 genetics, Coronary Artery Disease complications, Coronary Artery Disease genetics, Genome-Wide Association Study, Humans, Keratin-5 genetics, Linkage Disequilibrium genetics, Melanoma pathology, Membrane Proteins genetics, Molecular Sequence Data, Neoplasm Proteins genetics, Skin Neoplasms complications, Carcinoma, Basal Cell genetics, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide genetics, Skin Neoplasms genetics
- Abstract
In a follow-up to our previously reported genome-wide association study of cutaneous basal cell carcinoma (BCC), we describe here several new susceptibility variants. SNP rs11170164, encoding a G138E substitution in the keratin 5 (KRT5) gene, affects risk of BCC (OR = 1.35, P = 2.1 x 10(-9)). A variant at 9p21 near CDKN2A and CDKN2B also confers susceptibility to BCC (rs2151280[C]; OR = 1.19, P = 6.9 x 10(-9)), as does rs157935[T] at 7q32 near the imprinted gene KLF14 (OR = 1.23, P = 5.7 x 10(-10)). The effect of rs157935[T] is dependent on the parental origin of the risk allele. None of these variants were found to be associated with melanoma or fair-pigmentation traits. A melanoma- and pigmentation-associated variant in the SLC45A2 gene, L374F, is associated with risk of both BCC and squamous cell carcinoma. Finally, we report conclusive evidence that rs401681[C] in the TERT-CLPTM1L locus confers susceptibility to BCC but protects against melanoma.
- Published
- 2009
- Full Text
- View/download PDF
33. [Epilepsia partialis continua: an unusual complication of liver insufficiency].
- Author
-
Uterga JM, Corredera C, Barrallo G, and De Miguel F
- Subjects
- Aged, Female, Hepatic Encephalopathy complications, Humans, Epilepsia Partialis Continua etiology, Liver Failure complications
- Published
- 1995
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.